1. Home
  2. EXPO vs DYN Comparison

EXPO vs DYN Comparison

Compare EXPO & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$56.69

Market Cap

2.8B

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.96

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
DYN
Founded
1967
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.1B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
EXPO
DYN
Price
$56.69
$17.96
Analyst Decision
Buy
Strong Buy
Analyst Count
3
14
Target Price
$88.00
$37.00
AVG Volume (30 Days)
546.6K
1.4M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
N/A
EPS
0.59
N/A
Revenue
$582,014,000.00
N/A
Revenue This Year
$12.75
N/A
Revenue Next Year
$8.50
N/A
P/E Ratio
$93.85
N/A
Revenue Growth
4.21
N/A
52 Week Low
$51.91
$8.25
52 Week High
$81.95
$25.00

Technical Indicators

Market Signals
Indicator
EXPO
DYN
Relative Strength Index (RSI) 40.20 51.88
Support Level $51.91 $16.46
Resistance Level $73.75 $19.54
Average True Range (ATR) 1.90 1.04
MACD 0.11 0.01
Stochastic Oscillator 34.33 53.28

Price Performance

Historical Comparison
EXPO
DYN

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: